EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1

Sophia Marie Armbruster iD, Andres Caballero-Oteyza iD, Oliver Bartsch iD, Tiziana Lorenzini iD, Hassan Abolhassani iD, Samantha Chan iD, Luis Ignacio González Granado iD, Victor Garcia-Bustos iD, Marta Dafne Cabañero Navalon iD, Nazanin Fathi iD, Nima Rezaei iD, Mathieu Fusaro iD und 4 weitere

Journal of Human Immunity · 04.01.2027 · 3 (1)

DOI: 10.70962/jhi.20260076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 19.10.2026. Verfasst von Sophia Marie Armbruster und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Clinic of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency, Medical Center, Albert-Ludwigs-University o…. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bundesministerium für Forschung, Technologie und Raumfahrt, University of Freiburg.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous germline variants in NFKB1 can be classified into variants with “known protein defect” and “unknown protein effect.” However, beyond this, NFKB1 variants may be additionally categorized into at least eight distinct variant classes. We conducted a literature review of 67 papers reporting on NFKB1 variants and included four additional individuals, carrying previously unreported NFKB1 variants. We identified 333 individuals with unique variants in NFKB1. Our compiled data revealed that there is no sex predilection, the penetrance—including all heterozygous carriers—was 78%, and the mean age of onset for the “known protein defect cohort” was 21.2 years. Individuals harboring variants with a known protein defect demonstrated a higher frequency of malignancies and autoimmune disorders. However, these individuals were less frequently classified as affected than individuals with variants with unknown protein defect. Carriers of whole NFKB1 gene deletions had a significantly higher penetrance to being designated as “affected,” but beyond this, the clinical manifestations did not differ between variant classes.

Autor:innen und Institutionen

  • Faculty of Medicine, Clinic of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency, Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
  • Faculty of Medicine, Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
  • RESIST - Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg , Freiburg, Germany.
  • Department of Human Genetics, Medical Care Center, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Division of Immunology and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland.
  • Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Sophia Marie Armbruster, Andres Caballero-Oteyza, Oliver Bartsch, Tiziana Lorenzini, Hassan Abolhassani, Samantha Chan, Luis Ignacio González Granado, Victor Garcia-Bustos, Marta Dafne Cabañero Navalon, Nazanin Fathi, Nima Rezaei, Mathieu Fusaro, Roger Colobran, Kaan Boztug, Michele Proietti, Bodo Grimbacher

Förderung

  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • University of Freiburg
  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Armbruster, S. M., Caballero-Oteyza, A., Bartsch, O., Lorenzini, T., Abolhassani, H., Chan, S., González Granado, L. I., Garcia-Bustos, V., Cabañero Navalon, M. D., Fathi, N., Rezaei, N., Fusaro, M., Colobran, R., Boztug, K., Proietti, M., & Grimbacher, B. (2027). Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1. Journal of Human Immunity, 3(1). https://doi.org/10.70962/jhi.20260076

Vancouver

Armbruster SM, Caballero-Oteyza A, Bartsch O, Lorenzini T, Abolhassani H, Chan S, et al. Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1. Journal of Human Immunity. 2027;3(1). doi:10.70962/jhi.20260076

BibTeX
@article{Armbruster2027,
  author = {Armbruster, Sophia Marie and Caballero-Oteyza, Andres and Bartsch, Oliver and Lorenzini, Tiziana and Abolhassani, Hassan and Chan, Samantha and González Granado, Luis Ignacio and Garcia-Bustos, Victor and Cabañero Navalon, Marta Dafne and Fathi, Nazanin and Rezaei, Nima and Fusaro, Mathieu and Colobran, Roger and Boztug, Kaan and Proietti, Michele and Grimbacher, Bodo},
  title = {Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1},
  journal = {Journal of Human Immunity},
  year = {2027},
  volume = {3},
  number = {1},
  doi = {10.70962/jhi.20260076}
}
Kostenlos starten →